166 related articles for article (PubMed ID: 7835800)
21. Risk of ovarian cancer in BRCA1 and BRCA2 mutation-negative hereditary breast cancer families.
Kauff ND; Mitra N; Robson ME; Hurley KE; Chuai S; Goldfrank D; Wadsworth E; Lee J; Cigler T; Borgen PI; Norton L; Barakat RR; Offit K
J Natl Cancer Inst; 2005 Sep; 97(18):1382-4. PubMed ID: 16174860
[TBL] [Abstract][Full Text] [Related]
22. Ovarian intraepithelial neoplasia and ovarian cancer.
Gershenson DM; Tortolero-Luna G; Malpica A; Baker VV; Whittaker L; Johnson E; Follen Mitchell M
Obstet Gynecol Clin North Am; 1996 Jun; 23(2):475-543. PubMed ID: 8784888
[TBL] [Abstract][Full Text] [Related]
23. Effect of anovulation factors on pre- and postmenopausal ovarian cancer risk: revisiting the incessant ovulation hypothesis.
Tung KH; Wilkens LR; Wu AH; McDuffie K; Nomura AM; Kolonel LN; Terada KY; Goodman MT
Am J Epidemiol; 2005 Feb; 161(4):321-9. PubMed ID: 15692075
[TBL] [Abstract][Full Text] [Related]
24. Combined oral contraceptive use and epithelial ovarian cancer risk: time-related effects.
Lurie G; Wilkens LR; Thompson PJ; McDuffie KE; Carney ME; Terada KY; Goodman MT
Epidemiology; 2008 Mar; 19(2):237-43. PubMed ID: 18223481
[TBL] [Abstract][Full Text] [Related]
25. The myth about contraceptives and breast cancer.
Ibekwe J
Dly Times; 1993 Mar; ():7. PubMed ID: 12179509
[TBL] [Abstract][Full Text] [Related]
26. Association between clinical characteristics and risk-reduction interventions in women who underwent BRCA1 and BRCA2 testing: a single-institution study.
Uyei A; Peterson SK; Erlichman J; Broglio K; Yekell S; Schmeler K; Lu K; Meric-Bernstam F; Amos C; Strong L; Arun B
Cancer; 2006 Dec; 107(12):2745-51. PubMed ID: 17109443
[TBL] [Abstract][Full Text] [Related]
27. BRCA1 and BRCA2 germ-line mutations and oral contraceptives: to use or not to use.
Grenader T; Peretz T; Lifchitz M; Shavit L
Breast; 2005 Aug; 14(4):264-8. PubMed ID: 16085232
[TBL] [Abstract][Full Text] [Related]
28. Intra-abdominal carcinomatosis after prophylactic oophorectomy in women of hereditary breast ovarian cancer syndrome kindreds associated with BRCA1 and BRCA2 mutations.
Casey MJ; Synder C; Bewtra C; Narod SA; Watson P; Lynch HT
Gynecol Oncol; 2005 May; 97(2):457-67. PubMed ID: 15863145
[TBL] [Abstract][Full Text] [Related]
29. Advances in the management of epithelial ovarian cancer.
Memarzadeh S; Berek JS
J Reprod Med; 2001 Jul; 46(7):621-9; discussion 629-30. PubMed ID: 11499181
[TBL] [Abstract][Full Text] [Related]
30. Hormone replacement therapy and cancer.
Gynecol Endocrinol; 2001 Dec; 15(6):453-65. PubMed ID: 11826770
[TBL] [Abstract][Full Text] [Related]
31. Influence of selected lifestyle factors on breast and ovarian cancer risk in BRCA1 mutation carriers from Poland.
Gronwald J; Byrski T; Huzarski T; Cybulski C; Sun P; Tulman A; Narod SA; Lubinski J
Breast Cancer Res Treat; 2006 Jan; 95(2):105-9. PubMed ID: 16261399
[TBL] [Abstract][Full Text] [Related]
32. Oral contraceptive use and risk of breast cancer among women with a family history of breast cancer: a prospective cohort study.
Silvera SA; Miller AB; Rohan TE
Cancer Causes Control; 2005 Nov; 16(9):1059-63. PubMed ID: 16184471
[TBL] [Abstract][Full Text] [Related]
33. Epidemiology of ovarian cancer.
Permuth-Wey J; Sellers TA
Methods Mol Biol; 2009; 472():413-37. PubMed ID: 19107446
[TBL] [Abstract][Full Text] [Related]
34. Breast cancer risk factors and second primary malignancies among women with breast cancer.
Trentham-Dietz A; Newcomb PA; Nichols HB; Hampton JM
Breast Cancer Res Treat; 2007 Oct; 105(2):195-207. PubMed ID: 17186360
[TBL] [Abstract][Full Text] [Related]
35. Ovarian cancer.
Westhoff C
Annu Rev Public Health; 1996; 17():85-96. PubMed ID: 8724217
[TBL] [Abstract][Full Text] [Related]
36. Risk factors of ovarian cancer of epithelial origin: a case control study.
Koch M; Jenkins H; Gaedke H
Cancer Detect Prev; 1988; 13(2):131-6. PubMed ID: 3242822
[TBL] [Abstract][Full Text] [Related]
37. Ovarian cancer after hysterectomy.
McGowan L
Obstet Gynecol; 1987 Mar; 69(3 Pt 1):386-9. PubMed ID: 3822286
[TBL] [Abstract][Full Text] [Related]
38. Epidemiology and prevention of breast cancer.
Kelsey JL; Bernstein L
Annu Rev Public Health; 1996; 17():47-67. PubMed ID: 8724215
[TBL] [Abstract][Full Text] [Related]
39. Epidemiology and etiology of ovarian cancer: a review.
Heintz AP; Hacker NF; Lagasse LD
Obstet Gynecol; 1985 Jul; 66(1):127-35. PubMed ID: 3892386
[TBL] [Abstract][Full Text] [Related]
40. [Role of mass screening in detection of ovarian tumors].
Nikolaeva DV
Vopr Onkol; 1977; 23(3):68-74. PubMed ID: 143125
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
